RP13-565O16.1: A Potential Drug Target Or Biomarker (G54967)

Target Name: CT55

NCBI ID: G54967

RP13-565O16.1: A Potential Drug Target Or Biomarker

CT55 (CT55), also known as RP13-565O16.1, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of RNA-protein hybrids, which are characterized by the presence of both RNA and protein components in the same molecule.

The RP13-565O16.1 protein is of particular interest as a potential drug target or biomarker due to its unique structure and the involvement of several disease-related pathways. Its structure consists of a protein domain that is derived from the repetitive region of the T-cell receptor alpha chain, a transmembrane region, and a protein tail.

The protein is involved in several signaling pathways that are critical for various physiological processes in the body. One of the most significant roles of RP13-565O16.1 is in the regulation of cell adhesion, which is a critical process for tissue repair and regeneration.

RP13-565O16.1 is a negative regulator of the Focal Adhesion Protein (FAX), which is a transmembrane protein that is involved in cell-cell adhesion. FAX is a key protein that is involved in several processes in development, including tissue repair and regeneration.

In addition to its role in cell adhesion, RP13-565O16.1 is also involved in the regulation of cell proliferation and apoptosis. It is a negative regulator of the cyclin D1 gene, which encodes the cyclin D1 protein. The cyclin D1 protein is involved in the regulation of cell cycle progression and is a key protein in the G1 phase of the cell cycle.

RP13-565O16.1 is also involved in the regulation of inflammation. It is a negative regulator of the nuclear factor kappa B (NFkB), which is a protein that is involved in the regulation of inflammation and immune responses.

In conclusion, RP13-565O16.1 is a protein that is of particular interest as a potential drug target or biomarker due to its involvement in several disease-related signaling pathways. Its unique structure and multiple functions make it an attractive target for further research and development. Further studies are needed to fully understand the role of RP13-565O16.1 in various biological processes and to explore its potential as a drug or biomarker.

Protein Name: Cancer/testis Antigen 55

More Common Targets